The Korean Journal of Cytopathology (대한세포병리학회지)

The Korean Society for Cytopathology (대한세포병리학회)
권호 표지

Cytologic Features of Cancers Metastatic to the Lung and Diagnostic Usefulness of Immunohistochemistry : Distinction Between Primary and Secondary Lung Tumors

전이성 폐종양의 세포소견과 면역조직화학적 검사의 유용성

  • Oh, Young-Lyun (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 오영륜 (성균관대학교 의과대학 삼성서울병원 병리과)
  • Published : 2008.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The lungs are one of the most common visceral sites for metastatic disease. The identification of a metastasis from a second primary lung tumor is clinically important for patients with pulmonary metastases of an extrathoracic origin. Although the cytologic features of metastatic tumors involving the lung have been extensively described, making the cytologic diagnosis is usually not easy in the absence of clinical information. However, the immunohistochemical staining for many tumor markers and the different expressions of cytokeratin 7 and 20 are very useful in the diagnosis. This review presents the cytomorphological spectrum of metastatic tumors along with the immunohistochemical findings.

Keywords

References

  1. Yoneda KY, Louie S, Shelton DK. Approach to pulmonary metastases. Curr Opin Pulm Med 2000;6:356-63 https://doi.org/10.1097/00063198-200007000-00018
  2. Koss LG. Melamed MR. Koss' Diagnostic Cytology And Its Histopathologic Bases: Tumors of the lung. 5th edition. Lippincott Williams & Wilkins, 2005
  3. Koss LG, Melamed MR, Goodner JT. Pulmonary Cytology-a brief survey of diagnostic results from July 1st 1952 until December 31st, 1960. Acta Cytol 1964;8:104-13
  4. Giardini R, Martelli G, Rilke F, Pilotta S. Diagnostic problems of second primary malignancies detected by fine-needle aspiration cytology. Cancer 1993;72:2716-22 https://doi.org/10.1002/1097-0142(19931101)72:9<2716::AID-CNCR2820720932>3.0.CO;2-A
  5. Tan D, Zander DS. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update. Int J Clin Exp Pathol 2008:1:19-31
  6. McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979;22:553- 6 https://doi.org/10.1007/BF02587003
  7. Schulten MF, Heiskell CA, Shields TW. The incidence of solitary pulmonary metastasis from carcinoma of the large intestine. Surg Gynecol Obstet 1976;143:727-9
  8. Flint A, Lloyd RV. Colon carcinoma metastatic to the lung. Cytologic manifestations and distinction from primary pulmonary adenocarcinoma. Acta Cytol 1992;36:230-5
  9. Koizumi JH, Schron DS. Cytologic features of colonic adenocarcinoma. Differences between primary and metastatic neoplasms. Acta Cytol 1997;41:419-26 https://doi.org/10.1159/000332534
  10. Sack MJ, Roberts SA. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 1997;16:132-6 https://doi.org/10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J
  11. Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001;93:330-6 https://doi.org/10.1002/cncr.9048
  12. Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Cancer 2004;102:109-14 https://doi.org/10.1002/cncr.20110
  13. David D. Diagnostic Immunohistochemistry: Immunohistology of lung and pleural neoplasms. Second edition. Churchill Livingstone, 2006
  14. Di Nunno L, Larsson LG, Rinehart JJ, Beissner RS. Estrogen and progesterone receptors in non-small cell lung cancer in 248 consecutive patients who underwent surgical resection. Arch Pathol Lab Med 2000;124:1467-70
  15. Loy TS, Chapman RK, Diaz-Arias AA, Bulatao IS, Bickel JT. Distribution of BCA-225 in adenocarcinomas. An immunohistochemical study of 446 cases. Am J Clin Pathol 1991;96: 326-9 https://doi.org/10.1093/ajcp/96.3.326
  16. Brown RW, Campagna LB, Dunn JK, Cagle PT. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997;107:12- 9 https://doi.org/10.1093/ajcp/107.1.12
  17. Ciampa A, Fanger G, Khan A, Rock KL, Xu B. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas. Cancer 2004;102:368-72 https://doi.org/10.1002/cncr.20627
  18. Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol 2002;117:552-7 https://doi.org/10.1309/PCND-T3N0-5K01-D454
  19. Renshaw AA, Nappi D, Cibas ES. Cytology of metastatic adenocarcinoma of the prostate in pleural effusions. Diagn Cytopathol 1996;15:103-7 https://doi.org/10.1002/(SICI)1097-0339(199608)15:2<103::AID-DC4>3.0.CO;2-J
  20. Parwani AV, Ali SZ. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration. Diagn Cytopathol 2002;27:75-9 https://doi.org/10.1002/dc.10146
  21. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003;27:1031-51 https://doi.org/10.1097/00000478-200308000-00001
  22. Memeo L, Jhang J, Assaad AM, et al. Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma. Am J Clin Pathol 2007;127:225-9 https://doi.org/10.1309/9KWEA4W9Y94D1AEE
  23. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 2007;57:190-9 https://doi.org/10.1111/j.1440-1827.2007.02080.x
  24. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am J Surg Pathol 2001;25:1485-92 https://doi.org/10.1097/00000478-200112000-00003
  25. Gokden N, Mukunyadzi P, James JD, Gokden M. Diagnostic utility of renal cell carcinoma marker in cytopathology. Appl Immunohistochem Mol Morphol 2003;11:116-9 https://doi.org/10.1097/00129039-200306000-00004
  26. Simsir A, Chhieng D, Wei XJ, Yee H, Waisman J, Cangiarella J. Utility of CD10 and RCCma in the diagnosis of metastatic conventional renal-cell adenocarcinoma by fine-needle aspiration biopsy. Diagn Cytopathol 2005;33:3-7 https://doi.org/10.1002/dc.20272
  27. Renshaw AA, Haja J, Wilbur DC, Miller TR. Fine-needle aspirates of hepatocellular carcinoma that are misclassified as adenocarcinoma: correlating cytologic features and performance in the College of American Pathologists Nongynecologic Cytology Program. Arch Pathol Lab Med 2006;130:19-22
  28. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000;13:962-72 https://doi.org/10.1038/modpathol.3880175
  29. Onofre AS, Pomjanski N, Buckstegge B, Bocking A. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies. Cancer 2007;111:259-68 https://doi.org/10.1002/cncr.22768
  30. Siddiqui MT, Saboorian MH, Gokaslan ST, Ashfaq R. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration samples. Cancer 2002;96:49-52 https://doi.org/10.1002/cncr.10311
  31. Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid car- cinoma with distant metastases: survival predictors and the importance of local control. Surgery 2008;143:35-42 https://doi.org/10.1016/j.surg.2007.06.011
  32. Chen C, Hoda RS, Hoda SA. Intranuclear cytoplasmic inclusions in the differential diagnosis of papillary thyroid carcinoma and bronchioloalveolar carcinoma. Diagn Cytopathol 1998;18:384-6 https://doi.org/10.1002/(SICI)1097-0339(199805)18:5<384::AID-DC19>3.0.CO;2-E
  33. Goldstein NS, Thomas M. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies. Am J Clin Pathol 2001;116:319-25 https://doi.org/10.1309/550P-QLJX-D84W-F6DN
  34. Gaeta M, Volta S, Scribano E, Loria G, Vallone A, Pandolfo I. Air-space pattern in lung metastasis from adenocarcinoma of the GI tract. J Comput Assist Tomogr 1996;20:300-4 https://doi.org/10.1097/00004728-199603000-00025
  35. Geurts TW, Nederlof PM, van den Brekel MW, et al. Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005;11:6608-14 https://doi.org/10.1158/1078-0432.CCR-05-0257
  36. Renshaw AA, Madge R. Cercariform cells for helping distinguish transitional cell carcinoma from non-small cell lung carcinoma in fine needle aspirates. Acta Cytol 1997;41:999-1007 https://doi.org/10.1159/000332779
  37. Johnson TL, Kini SR. Cytologic features of metastatic transitional cell carcinoma. Diagn Cytopathol 1993;9:270-8 https://doi.org/10.1002/dc.2840090306
  38. Layfield LJ, Jones C, Hirschowitz S. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies. Diagn Cytopathol 2003;29:334-8 https://doi.org/10.1002/dc.10380
  39. Renshaw AA, Madge R, Granter SR. Intracytoplasmic eosinophilic inclusions (Melamed-Wolinska bodies). Association with metastatic transitional cell carcinoma in pleural fluid. Acta Cytol 1997;41:995-8 https://doi.org/10.1159/000332778
  40. Bassily NH, Vallorosi CJ, Akdas G, Montie JE, Rubin MA. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol 2000;113:383-8 https://doi.org/10.1309/G1RA-EU9X-X6VV-3W79
  41. Moll R, Laufer J, Wu XR, Sun TT. Uroplakin III, a specific membrane protein of urothelial umbrella cells, as a histological markers for metastatic transitional cell carcinomas. Verh Dtsch Ges Pathol 1993;77:260-5
  42. Kaufmann O, Volmerig J, Dietel M. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 2000;113:683-7 https://doi.org/10.1309/PYQC-17CB-063T-Q07J
  43. Langner C, Ratschek M, Tsybrovskyy O, Schips L, Zigeuner R. P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors. J Histochem Cytochem 2003; 51:1097-9 https://doi.org/10.1177/002215540305100813
  44. Shin HJ, Caraway NP. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol 1998;19:177-81 https://doi.org/10.1002/(SICI)1097-0339(199809)19:3<177::AID-DC4>3.0.CO;2-A
  45. Kim K, Naylor B, Han IH. Fine needle aspiration cytology of sarcomas metastatic to the lung. Acta Cytol 1986;30:688- 94